On the other hand, 2 studies (16.7%) observed p53 expression only among women with phyllodes tumors (Feakins et al., 1999; Niezabitowski et al., 2001), showing great differences between p53 expression in totally benign, borderline and malignant lesions. The gene discussed is TP53; the disease is phyllodes tumor.